| Nasopharyngeal carcinoma MLK Chua, JTS Wee, EP Hui, ATC Chan The Lancet 387 (10022), 1012-1024, 2016 | 1335 | 2016 |
| Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors W Yeo, PKS Chan, S Zhong, WM Ho, JL Steinberg, JS Tam, P Hui, ... Journal of medical virology 62 (3), 299-307, 2000 | 890 | 2000 |
| Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab W Yeo, TC Chan, NWY Leung, WY Lam, FKF Mo, MT Chu, HLY Chan, ... Journal of Clinical Oncology 27 (4), 605-611, 2009 | 813 | 2009 |
| A randomized phase III study of doxorubicin versus cisplatin/interferon α-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma W Yeo, TS Mok, B Zee, TWT Leung, PBS Lai, WY Lau, J Koh, FKF Mo, ... Journal of the National Cancer Institute 97 (20), 1532-1538, 2005 | 798 | 2005 |
| Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis P Blanchard, A Lee, S Marguet, J Leclercq, WT Ng, J Ma, ATC Chan, ... The lancet oncology 16 (6), 645-655, 2015 | 742 | 2015 |
| Overall survival after concurrent cisplatin–radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma ATC Chan, SF Leung, RKC Ngan, PML Teo, WH Lau, WH Kwan, EP Hui, ... Journal of the National Cancer Institute 97 (7), 536-539, 2005 | 714 | 2005 |
| Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma EP Hui, BB Ma, SF Leung, AD King, F Mo, MK Kam, BK Yu, SK Chiu, ... Journal of clinical oncology 27 (2), 242-249, 2009 | 664 | 2009 |
| Analysis of plasma Epstein–Barr virus DNA to screen for nasopharyngeal cancer KCA Chan, JKS Woo, A King, BCY Zee, WKJ Lam, SL Chan, SWI Chu, ... New England Journal of Medicine 377 (6), 513-522, 2017 | 645 | 2017 |
| Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing KCA Chan, P Jiang, CWM Chan, K Sun, J Wong, EP Hui, SL Chan, ... Proceedings of the National Academy of Sciences 110 (47), 18761-18768, 2013 | 469 | 2013 |
| Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma ATC Chan, MM Hsu, BC Goh, EP Hui, TW Liu, MJ Millward, RL Hong, ... Journal of clinical oncology 23 (15), 3568-3576, 2005 | 409 | 2005 |
| Coexpression of hypoxia-inducible factors 1α and 2α, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival EP Hui, ATC Chan, F Pezzella, H Turley, KF To, TCW Poon, B Zee, F Mo, ... Clinical Cancer Research 8 (8), 2595-2604, 2002 | 406 | 2002 |
| Antitumor activity of nivolumab in recurrent and metastatic nasopharyngeal carcinoma: an international, multicenter study of the mayo clinic phase 2 consortium (NCI-9742) BBY Ma, WT Lim, BC Goh, EP Hui, KW Lo, A Pettinger, NR Foster, ... Journal of Clinical Oncology 36 (14), 1412, 2018 | 392 | 2018 |
| Plasma Epstein-Barr viral deoxyribonucleic acid quantitation complements tumor-node-metastasis staging prognostication in nasopharyngeal carcinoma S Leung, B Zee, BB Ma, EP Hui, F Mo, M Lai, KCA Chan, LYS Chan, ... Journal of clinical oncology 24 (34), 5414-5418, 2006 | 389 | 2006 |
| Exome and genome sequencing of nasopharynx cancer identifies NF-κB pathway activating mutations YY Li, GTY Chung, VWY Lui, KF To, BBY Ma, C Chow, JKS Woo, KY Yip, ... Nature communications 8 (1), 14121, 2017 | 296 | 2017 |
| New utility of an old marker: serial α-fetoprotein measurement in predicting radiologic response and survival of patients with hepatocellular carcinoma undergoing systemic … SL Chan, FKF Mo, PJ Johnson, EP Hui, BBY Ma, WM Ho, KC Lam, ... Journal of Clinical Oncology 27 (3), 446-452, 2009 | 287 | 2009 |
| Hepatitis B virus reactivation in breast cancer patients receiving cytotoxic chemotherapy: a prospective study W Yeo, PKS Chan, P Hui, WM Ho, KC Lam, WH Kwan, S Zhong, ... Journal of medical virology 70 (4), 553-561, 2003 | 281 | 2003 |
| Nasopharyngeal cancer: EHNS–ESMO–ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up ATC Chan, V Grégoire, JL Lefebvre, L Licitra, EP Hui, SF Leung, E Felip Annals of oncology 23, vii83-vii85, 2012 | 267 | 2012 |
| Nasopharyngeal carcinoma: an evolving paradigm KCW Wong, EP Hui, KW Lo, WKJ Lam, D Johnson, L Li, Q Tao, ... Nature reviews Clinical oncology 18 (11), 679-695, 2021 | 260 | 2021 |
| Analysis of plasma Epstein-Barr virus DNA in nasopharyngeal cancer after chemoradiation to identify high-risk patients for adjuvant chemotherapy: a randomized controlled trial ATC Chan, EP Hui, RKC Ngan, SY Tung, ACK Cheng, WT Ng, VHF Lee, ... Journal of clinical oncology 36 (31), 3091-3100, 2018 | 214 | 2018 |
| Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up P Bossi, AT Chan, L Licitra, A Trama, E Orlandi, EP Hui, J Halámková, ... Annals of Oncology 32 (4), 452-465, 2021 | 213 | 2021 |
Brigette BY MaThe Chinese University of Hong KongVerified email at clo.cuhk.edu.hk
